To assess the effect of edited AZIN1 in CRC progression, we performed xenograft experiments using AZIN1 overexpressing HCT 116 colon cancer cells mixed with HUVEC to confirm our in vitro findings. The gene discussed is AZIN1; the disease is colorectal carcinoma.